Physiologic effects of prone positioning on gas exchange and ventilation-perfusion matching in awake patients with AHRF Authors: Yali Chao, Xueyan Yuan, Zhanqi Zhao, Inéz Frerichs, Zhe Li, Qin Sun, Dongyu Chen, Rui Zhang, Haibo Qiu, Ling Liu Published: 2024 ABSTRACT AbstractBackgroundProne positioning (PP) improves oxygenation in awake patients with acute hypoxemic respiratory failure (AHRF). However, the underlying mechanisms remain unclear in patients with diverse lung morphology. We aimed to determine the short-term effects of awake prone positioning (APP) in AHRF patients with focal and non-focal lung morphology.MethodsThis is a prospective physiological study. Twenty-four non-intubated patients with PaO2/FiO2 ≤ 300 mm Hg were included. Gas exchange, ventilation and perfusion distribution, and hemodynamics variables were recorded in the supine position (SP1), 2 h after PP, and 1 h after re-supine (SP2). Lung morphology was classified as focal and non-focal patterns using computed tomography.ResultsTwelve of the included patients were classified to the focal group and 12 to the non-focal group. PaO2/FiO2 improved after PP in all patients (161 [137, 227] mmHg vs. 236 [202, 275] mmHg, p < 0.001). Ventilation-perfusion (V/Q) matching increased after PP in all patients (61.9 [53.9, 66.5] vs. 77.5 [68.3, 80.0], p < 0.001). Shunt exhibited a significant decrease in patients of the non-focal group (28.6 [22.5, 30.3] vs. 11.3 [9.0, 14.5], p < 0.001), whereas no difference was found in the focal group after PP. Dead space decreased significantly in patients of the focal group (25.6 [21.5, 28.4] vs. 12.0 [10.8, 14.1], p < 0.001), whereas no difference was found in the non-focal group after PP.ConclusionsAPP improves V/Q matching, and large-scale, bias-free studies are needed to find more definitive differences between patients with focal and non-focal lung morphyology.Trial registrationThe study is registered in ClinicalTrials.gov (trial No. NCT04754113, date of registration: 2021-02-15).Supplementary InformationThe online version contains supplementary material available at 10.1186/s12890-024-03411-0.Keywords: Awake prone positioning, Ventilation-perfusion matching, Shunt, Dead space, Acute hypoxemic respiratory failure Introduction Prone positioning is an effective intervention to reduce mortality and has been commonly used for many years [1, 2]. Prone positioning reduces intrapulmonary shunt and facilitates lung recruitment, further optimizing ventilation/perfusion matching [3]. While the mechanisms behind the prone positioning are more complex. In mechanically ventilated patients, prone positioning improves oxygenation while achieving a more homogeneous distribution of the mechanical forces, therefore reducing lung injury [4, 5]. In recent years, the use of awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure (AHRF) has been implemented in clinical practice due to its beneficial effect on the oxygenation and clinical outcomes [6–9]. However, the exact mechanisms leading to the oxygenation improvement remain unclear. Only few studies have addressed the physiological effects of prone positioning in awake patients, most of which have only demonstrated the change of regional distribution of ventilation and effort-to-breathe after proning [10–12]. As oxygenation improvement may involve changes in the distribution of either ventilation and/or perfusion that may both affect regional ventilation/perfusion (V/Q) matching, it is essential to consider the distribution of regional pulmonary blood flow following awake prone positioning [13]. Electrical impedance tomography (EIT), as a bedside, real-time, free-radiation technology, has been identified to detect pulmonary blood flow, particularly when using hypertonic saline as a “conductive” contrast agent [14]. Therefore, EIT is a useful tool for assessing the potential mechanisms affecting the distribution of both ventilation and perfusion during awake prone positioning. In recent, two crossover trials evaluated the effects of awake prone positioning using EIT. Both studies showed that while awake prone positioning improved oxygenation, it was not associated with improved lung ventilaton homogeneity [15, 16]. In this study, we use EIT to continuously record regional lung ventilation and perfusion in patients with AHRF and we hypothesize that the effects of awake prone positioning in improving V/Q matching by reducing shunt and dead space may differ among patients exhibiting diverse lung morphology. Methods This prospective observational study was performed in the medical ICU at Zhongda Hospital, Southeast University from May 2021 to March 2022. The study protocol was granted approval by the Institutional Ethics Committee of Zhongda hospital, Southeast University (2020ZDSYLL057-P01). Written informed consent was obtained from patients before enrollment. For patients who were unable to write due to underlying medical conditions, written informed consent were obtained from the patients’ legal representatives with their authorization. This was a prospective, observational cohort study registered in ClinicalTrials.gov (NCT04754113, date of registration: 2021-02-15). Study population All adults (> 18 years) admitted to our ICU were enrolled if they met the following criteria: (1) a ratio of the partial pressure of arterial oxygen (PaO2) to the FiO2 (PaO2/FiO2) ≤ 300 mm Hg while the patient was breathing oxygen at a flow rate of 10 L per minute or more for at least 15 min [17], (2) evidence of bilateral pulmonary infiltrates on a chest radiograph or a CT scan, (3) an acute onset (< 1 week) of respiratory distress, (4) a partial pressure of arterial carbon dioxide (PaCO2) ≤ 45 mm Hg, and (5) no history of chronic respiratory failure. Exclusion criteria were as follows: contraindication to EIT use (presence of pacemaker), prior intubation, contraindications to prone positioning, poor tolerance and/or severe worsening of clinical conditions during study phases necessitating prone positioning discontinuation, a lack of ability to hold the breath, a lack of central venous catheter, and refusal to participate in this study. Study protocol Demographic data (age, sex, body mass index [BMI]), cause of AHRF, type of supplemental oxygen, time from symptoms onset to hospital admission and ICU admission, and time from hospital admission to awake prone positioning were collected. Chest CT scan in the supine position was collected at enrollment. Upon enrollment, each patient was assigned to either standard oxygen therapy or high-flow nasal cannula (MR860 or ARIVO2, Fisher and Paykel healthcare), as determined by the clinical clinician. This assignment remained unchanged throughout the study period. All patients were examined in the supine position at baseline (SP1), 2 h after prone positioning initiation (PP), and 1 h after re-positioning to the supine posture (SP2). The respiratory rate (RR), peripheral capillary oxygen saturation (SpO2), arterial blood gas analysis (pH, PaO2, PaCO2, PaO2/FiO2), hemodynamic parameters (heart rate and mean arterial pressure), and EIT data were recorded during the last five-minute period of each of the three phases. The use of sedative or analgesic agents which could have interfered with the breathing pattern was not allowed during the study period. EIT data EIT measurements were performed using PulmoVista 500 (Dräger Medical GmbH, Lübeck, Germany) at 50 Hz and the data were stored for offline analysis. The 16-electrode EIT belt was placed along the fourth to fifth intercostal space and kept in the same position during the whole study period. Regional ventilation maps were calculated by averaging tidal impedance variation (the difference between end-inspiratory and end-expiratory impedance) after the bolus during the last 1 min of the 5-min long data acquisition. Regional perfusion maps were generated by the slope of the impedance decrease with a saline bolus injection strategy [18]. The patients were asked to perform an end-expiratory breath-hold for 8–12 s, and then a bolus of 10 mL of 10% NaCl solution was quickly injected through a central venous catheter 2 s after the voluntary onset of airway occlusion. The following parameters were calculated in the last minute of each study phase: (1) the percentage of total ventilated lung area that is located in the dorsal half of the thorax [19], (2) the percentage of total perfused lung area that is located in the dorsal half of the thorax [19], (3) the global inhomogeneity (GI) index [20]. Subsequently, the following regions were identified [19]: (1) shunt %: all pixels that were only perfused, divided by the total number of pixels classified as ventilated or perfused. (2) dead space %: all pixels that were only ventilated, divided by the total number of pixels classified as ventilated or perfused. (3) V/Q matching %: corresponding to the pixels that were both ventilated and perfused divided by the total number of pixels ventilated or perfused. Lung morphology assessment The chest CT was obtained within 48 h prior to or following the onset of study period. All CT scans were performed in the supine position. CT images were analyzed by two intensivists and one radiologist who were blinded to patient’s history. Patterns of lung morphology were considered as “focal” in the presence of consolidations localized only in the lower lobes or gravitationally dependent parenchyma, and as “non-focal” if diffuse or patchy consolidations were identified in the lung parenchyma [21]. Endpoints The primary endpoint was changes in V/Q matching with positions accroding to the CT pattern. The secondary endpoints were the percentage of shunt, the percentage of dead space, the percentage of dorsal ventilated area, the percentage of dorsal perfused area, the GI index, pH, PaO2, PaO2/FiO2, PaCO2, RR, heart rate, and mean arterial pressure in different positions. A patient was an oxygenation responder when a relative increase in PaO2/FiO2 by 20% or more was noted after prone positioning [11]. Statistical analysis Considering the lack of previous studies’ results, sample size calculation was unattainable in our study. Data were tested for normality distribution by Shapiro-Wilk test. Continuous variables were reported as mean (± standard deviation) or median (interquartile range [IQR]) for continuous variables, as appropriate. Categorical variables were reported as numbers (percent). For the analysis of variables with normal distribution, Mauchly’s test was performed for sphericity, and repeated measures ANOVA was used with post hoc Bonferroni’s multiple comparisons. If not normally distributed, the change of variables at the different timepoints were compared using Kruskal-Wallis test. Greenhouse-Geisser method was applied for correction when Mauchly’s test p value was < 0.05. A level of two-tailed p < 0.05 was considered as statistically significant. Statistical analyses were conducted using STATA version 19.0 (Statacorp, College Station, TX, USA) and Prism (GraphPad Prism v9.3, La Jolla, CA). Results Patients’ characteristics Twenty-four patients were enrolled in the study. Twelve patients were classified to the focal lung morphology group and twelve to the non-focal lung morphology group (Figure E1). The patients in the non-focal group were older than patients in the focal group (P = 0.037). The use of nasal oxygen was no difference between patients in the focal group and non-focal group (33% vs. 25%, P < 0.653). There were no significant differences in other characteristics between the two groups. Additional details are summarized in Table 1. Table 1Baseline characteristics of the study patientsVariableOverallN = 24Focal groupN = 12Non-focal groupN = 12 P Age (years)67 [56, 73]61 [54, 68]73 [62, 75]0.037Sex, male, n (%)17 (70.8)7 (58.3)10 (83.3)0.178BMI (kg/m2)24.1 [22.8, 26.4]23.8 [21.7, 26.8]24.5 [23.3, 25.3]0.885Cause of AHRF0.319 Community-acquired pneumonia844 COVID-191486 Extrapulmonary sepsis202Type of supplemental oxygen0.653 Nasal tube oxygen, n (%)7 (29.2)4 (33.3)3 (25.0) HFNC, n (%)17 (70.8)8 (66.7)9 (75.0)FIO2, %41.2 ± 11.439.7 ± 13.642.8 ± 8.90.519HFNC gas flow, L/min48.5 ± 4.947.5 ± 4.649.2 ± 5.10.461Time from syndrome onset to hospital admission, d5.5 [3, 8]5.5 [3.5, 8]5 [3, 7]0.640Time from syndrome onset to ICU admission, d6 [3, 8.5]6.5 [3.5, 8]5.5 [3, 11]0.793Time from hospital admission to awake prone position, d0.8 [0.5, 3.5]0.8 [0.5, 2.5]0.8 [0.5, 4.0]0.908Length of ICU stay, d18 [14, 22.5]19.5 [15, 28.5]17.5 [14, 21.5]0.50628-day mortality0001.00BMI, body mass index; AHRF, acute hypoxemic respiratory failure; HFNC, high-flow nasal cannula Baseline characteristics of the study patients BMI, body mass index; AHRF, acute hypoxemic respiratory failure; HFNC, high-flow nasal cannula Comparisons between SP1 and PP Gas exchange and hemodynamics variables After proning, PaO2/FiO2 improved in both group (both P < 0.01) (Fig. 1A). Seven (54%) patients in the focal group and ten patients (91%) in the non-focal group were classified as oxygenation responders (Figure E2). pH and PaCO2 did not significantly change after PP in both groups. RR did not change between SP1 and PP (Table 2). For the hemodynamics variables, both heart rate and mean arterial pressure were not affected by the body position in both groups (Table 2). Individual patients’ values of PaO2/FiO2 (A) and ventilation-perfusion match (B) during the three phases of the study. The thick black lines represent the median. SP1, supine at baseline; PP, prone position; SP, re-supine. *p < 0.05, **p < 0.01, ***p < 0.001 Table 2Gas exchange, EIT-related variables, and hemodynamics variables during the study periodFocal group, N = 12 P Non-focal group, N = 12 P SP1PPSP2SP1PPSP2Gas exchange pH7.46 ± 0.067.45 ± 0.057.45 ± 0.050.1447.43 ± 0.067.44 ± 0.047.44 ± 0.040.521 PaO2, mmHg73.7 [58.5, 80.2]89.2 [75.0, 99.2]*74.8 [60.1, 80.4]# < 0.001 68.6 [58.5, 81.8]94.0 [78.8, 106.8]*82.0 [68.8, 89.8]# < 0.001 PaO2/FIO2, mmHg191 [143, 240]237 [196, 270]*212 [144, 254]# < 0.001 142 [129, 208]235 [202, 282]*205 [153, 224]# < 0.001 PaCO2, mmHg35.9 ± 4.138.2 ± 3.137.4 ± 3.00.22133.6 ± 7.333.2 ± 6.234.0 ± 5.50.635Respiratory rate, breaths/min23 ± 524 ± 425 ± 60.33725 ± 624 ± 325 ± 60.563EIT-based measures Global inhomogeneity index0.40 [0.36, 0.50]0.41 [0.36, 0.47]0.42 [0.38, 0.46]0.9130.39 [0.36, 0.44]0.40 [0.37, 0.43]0.39 [0.36, 0.48]0.913 Ventilated area, dorsal, %52.9 ± 13.156.9 ± 10.450.8 ± 12.90.13247.4 ± 17.453.5 ± 14.446.6 ± 18.70.428 Perfused area, dorsal, %54.8 ± 14.052.4 ± 11.950.4 ± 15.90.60644.1 ± 9.551.4 ± 11.146.7 ± 11.50.126 Shunt, %10.8 [5.5, 20.5]11.5 [7.4, 16.8]11.1 [5.0, 24.2]0.55828.6 [22.5, 30.3]11.3 [9.0, 14.5]*16.9 [9.5, 25.1]* < 0.001 Dead space, %25.6 [21.5, 28.4]12.0 [10.8, 14.1]*20.3 [14.7, 27.8] < 0.001 13.6 [6.8, 17.8]12.5 [7.4, 19.0]15.0 [10.1, 19.1]0.472 Ventilation-perfusion matching, %62.6 [52.6, 71.9]78.6 [69.7, 81.4]*65.1 [58.2, 73.6]# < 0.001 61.9 [54.3, 63.1]76.0 [68.7, 79.0]*62.5 [61.0, 69.2]# < 0.001 Hemodynamic data Heart rate, beats/min87 ± 1485 ± 1580 ± 13* 0.033 90 ± 1594 ± 1590 ± 170.146 Mean arterial pressure, mmHg86 ± 1188 ± 1088 ± 130.58286 ± 1185 ± 1084 ± 100.707SP1, supine at baseline; PP, prone position; SP, re-supine. *p < 0.05 supine versus prone, #p < 0.05 prone versus re-supine Gas exchange, EIT-related variables, and hemodynamics variables during the study period SP1, supine at baseline; PP, prone position; SP, re-supine. *p < 0.05 supine versus prone, #p < 0.05 prone versus re-supine Ventilation, perfusion, and V/Q distribution The change in the V/Q matching after PP is presented in the Table 2, Table E1, and Fig. 1B. V/Q matching increased significantly in both groups after proning (both p < 0.001). The percentages of shunt and dead sapce in SP1 and PP are presented in the Table 2; Fig. 2. For patients in the focal group, PP reduced the percentage of dead sapce but did not affect the percentage of shunt. Conversely, in patients in the non-focal group, PP reduced the percentage of shunt but did not impact the percentage of dead space. Individual patients’ values of the percentage of shunt (A) and dead space (B) during the three phases of the study. The thick black lines represent the median. SP1, supine at baseline; PP, prone position; SP, re-supine. ***p < 0.001 Comparisons between PP and SP2 Gas exchange and hemodynamics variables For patients in both groups, PaO2/FiO2 decreased significantly in the SP2 when compared with PP (Fig. 1A). Patients in both groups were not different in the PaCO2 and RR between PP and SP2 (Table 2). Regarding the hemodynamics, neither heart rate nor mean arterial pressure in both groups showed any changes in the SP2 compared to PP (Table 2). Ventilation, perfusion, and V/Q distribution From PP to SP2, V/Q matching had significantly decreased in patients with both groups (Fig. 1B). For the percentage of shunt dead space, patients in both groups did not change from PP to SP2 (Fig. 2B). The physiologic effects of awake prone positioning on the distribution of pulmonary ventilation and perfusion in two representative patients determined by EIT, are presented in the Figure E3 and Figure E4. Subgroup analysis To identify the effect of the type of supplemental oxygen (nasal oxygen vs. HFNC) and cause of AHRF (COVID-19 vs. Non-COVID-19) on the EIT-related variables. In patients with different types of supplemental oxygen, the results showed that patients with HFNC were more likely to benefit from APP based on gas exchange and ventilation-perfusion distribution (Table E2). In patients with different causes of AHRF, the result showed that APP could reduce the percent of dead space in the patients with COVID-19 (Table E3). Correlations between change in PaO2/FiO2 and V/Q distribution The relative variations in the PaO2/FiO2 during the PP session were inversely correlated with change in the percent of shunt (r = -0.46, P = 0.025) (Fig. 3B). However, no correlation was observed between the relative variations in the PaO2/FiO2 and the change in the percentage of V/Q matching (Fig. 3A) and dead space (Fig. 3C). Correlation between difference of PaO2/FiO2 and ventilation-perfusion matching (A), shunt (B), and dead space (C). Difference of PaO2/FiO2 was defined as the change of PaO2/FiO2 from SP1 to PP. Each solid circle represents one patient with focal lung morphology. Each empty circle represents one patient with non-focal lung morphology. The dotted line represents 95% confidence intervals, while the solid line represents the regression line Discussion The primary findings of this study are as follows: Awake prone positioning improved both V/Q matching and oxygenation in patients with AHRF, irrespective of lung morphology. Among patients with focal lung morphology, V/Q matching was improved by the reduced percentage of lung units with dead space ventilation. Among patients with non-focal lung morphology, V/Q matching was improved by the decreased percentage of shunt lung units. The beneficial effect of awake prone positioning on the oxygenation improvement has been explored in several studies, especially in the context of the COVID-19 pandemic [11–13]. Nevertheless, discrepancies persist concerning oxygenation endpoints, the duration of prone positioning, and the respiratory support devices used in these studies [6, 9, 22]. A previous study reported that awake prone positioning induced a marked increase of PaO2/FiO2 of 20% or more in up to 85% of patients [23]. In the present study, we observed a significant increase in the PaO2/FiO2 at PP. Consistent with previous studies, our current study revealed that oxygenation improvement was independent of the baseline degree of hypoxemia, suggesting that basing the decisions on implementation of awake prone positioning on PaO2/FiO2 levels may not be reliable [23]. Furthermore, we confirmed that the effect of awake prone positioning on the oxygenation improvement was lost after repositioning to the supine posture, which was in line with previous studies [12, 13, 24]. Almost 70% of patients were classified as responders, showing a clinically significant increase in PaO2/FiO2 of 20% or more in the present study. This is comparable to the 65% reported in the previous study [11]. The physiological effects of awake prone positioning in the non-intubated patients with AHRF are not yet fully understood. In mechanically ventilated patients, following PP, the decrease of pleural pressure gradient from non-dependent to dependent regions reopens non-aerated or poorly aerated regions, therefore, reinforcing a more homogeneous ventilation [25]. Notably, in the present study, the GI index, which reflects lung inhomogeneity, showed no change following PP. This finding is consistent with results from two previous small trials [15, 16]. Therefore, the benefit in the oxygenation could be explained by the redistribution of pulmonary blood flow and optimisation of ventilation/perfusion matching. In the present study, V/Q matching increased after awake prone positioning regardless of the lung morphology. However, there were still some differences in the effects of awake prone positioning among patients with different lung morphology, which were revealed in our study. The possible explaination for this discrepancy may included (1) The effect of HFNC: there was a slightly higher percentage of HFNC use with higher gas flow in patients with non-focal group, although the use of HFNC did not differ significantly between groups. The physiological effects of HFNC including reduced dead space, improved lung recruitment and oxygenation were associated with flow rate and change significantly with increases [26]. (2) Patient type: 60% of COVID-19 patients were included in our study. The CT patterns and lung lesions in COVID-19 patients could be differ compared to those with pneumonia or extrapulmonary sepsis. (3) The identification of EIT map: the shunt and dead space regions were identified using pixels for manual calculations, which may lead to calculation deviations. (4) A small sample size: we only included 12 patients in each group. The sample size may have been insufficient to detect a clinically significant treatment effect. Our study has some limitations. First, the respiratory parameters, including esophageal pressure, trans-diaphragmatic pressure, tidal volume, and work of breathing was not measured which may affect the evaluation of the effects of awake prone positioning. Second, the long-term effects of awake prone positioning are missing, whether the short-term beneficial effects translate into improved clinically relevant outcome is unclear. Third, EIT cannot provide images of the whole lung, so the assessment of the entire spectrum of V/Q matching in the whole lung was not accessible. Forth, our study population was relatively small, but more than the sample size in previous studies on the physiological effect of awake prone positioning. Conclusion Awake prone positioning improves oxygenation and V/Q matching in AHRF patients regardless of lung morphology. Large-scale, bias-free studies are needed to find more definitive differences between patients with focal and non-focal lung morphology. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements All authors were responsible for data interpretation, revised the manuscript critically, and approved the version submitted for publication. Abbreviations Prone positioning Awark prone positioning Acute hypoxemic respiratory failure Supine positioning Partial pressure of arterial oxygen Partial pressure of arterial carbon dioxide Eletrical impedance tomography Ventilation-perfusion Body mass index Author contributions HQ and LL had the idea of the study, conceptualized the research aims, YC, ZZ, DC, and XY design the study and take responsibility for the integrity of the data and the accuracy of the data analysis. QS, RZ, and ZL performed the data processing and experimental analysis, XY doing the statistical analysis, YC and XY wrote the first draft of the paper, Inéz acquired the data and critically revised the manuscript. All authors read and approved the final manuscript. Funding This work was funded by National Science and Technology Major Project of China (2022YFC2504400), the National Natural Science Foundation of China (82341032 and 81930058), the Second Level Talents of the “333 High Level Talents Training Project” in the sixth phase in Jiangsu (LGY2022025), and Jiangsu Provincial Key Laboratory of Critical Care Medicine (BM2020004). Data availability The data that support the findings of this study are available upon reasonable request from the corresponding author. Declarations Ethics approval and consent to participate The study protocol was approved by the local ethics committee for clinical research of Zhongda Hospital, Southeast University (2020ZDSYLL057-P01). Written informed consent was obtained from patients before enrollment. For patients who were unable to write due to underlying medical conditions, written informed consent were obtained from the patients’ legal representatives with their authorization. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The data that support the findings of this study are available upon reasonable request from the corresponding author.